Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019032975) ABUSE-RESISTANT DRUG FORMULATIONS
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/032975 International Application No.: PCT/US2018/046237
Publication Date: 14.02.2019 International Filing Date: 10.08.2018
IPC:
A61K 47/36 (2006.01) ,A61K 47/50 (2017.01) ,A61K 47/32 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
36
Polysaccharides; Derivatives thereof
[IPC code unknown for A61K 47/50]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
32
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
Applicants:
MEC DEVICE PHARMA INTERNATIONAL LLC [US/US]; 4010 SW 30th Avenue Fort Lauderdale, FL 33312, US
Inventors:
OMIDIAN, Hossein; US
JOSHI, Yogesh, N.; US
AHMAD, Rand Husni, Mahmoud; US
Agent:
KIM, Stanley, A.; US
Priority Data:
62/543,60310.08.2017US
Title (EN) ABUSE-RESISTANT DRUG FORMULATIONS
(FR) FORMULATIONS DE MÉDICAMENT ANTI-ABUS
Abstract:
(EN) Abuse-resistant therapeutic pharmaceutical formulations include a cationic drug and at least one anionic polymer. Particular arrangements of the cationic drug and the at least one anionic polymer prevent the cationic drug from being extracted from the formulations in solvents and conditions commonly used by drug abusers attempting to isolate the cationic drug from its formulation.
(FR) Des formulations pharmaceutiques thérapeutiques anti-abus contiennent un médicament cationique et au moins un polymère anionique. Des conceptions particulières du médicament cationique et dudit au moins un polymère anionique empêchent le médicament cationique d'être extrait des formulations dans des solvants et dans des conditions fréquemment utilisées par des personnes pharmacodépendantes essayant d'isoler le médicament cationique de sa formulation.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)